SIME is committed to preventative, personalized point-of-care medicine, with a focus on addressing urgent unmet needs in the neonatal intensive care unit. Their data engine detects disease in real-time, enabling early treatment in high-risk patients. SIME's AI platform generates unique datasets which can be used to discover new products or biomarkers, and they have over three decades of experience in pioneering innovation in medicine and data science. Their clinically proven technology enables early intervention in life-threatening diseases, improving outcomes and reducing costs.